Recent Developments in Group I Metabotropic Glutamate Receptor Allosteric Modulators for the Treatment of Psychiatric and Neurological Disorders (2014-May 2015)

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3470-3526

Bentham Science Publishers

Access to resources Recommend Favorite

AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3536-3565

Bentham Science Publishers

Access to resources Recommend Favorite

Positive Allosteric Modulators (PAMs) of Metabotropic Glutamate Receptor 5 (mGluR5) Attenuate Microglial Activation

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 558-566

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 (mGluR5)

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-08 ,pp. : 825-846

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Developement of Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2

By  

Current Medicinal Chemistry, Vol. 18, Iss. 1, 2011-01 ,pp. : 47-68

Bentham Science Publishers

Access to resources Recommend Favorite